Effect of simvastatin on ejection fraction in cardiac transplant recipients

American Journal of Cardiology

Volumn 78, Issue 12, 1996, Pages 1453-1456

  Jenkins, Geraint H ^a,b   Grieve, Lesley A ^a   Yacoub, Magdi H ^a   Singer, Donald R J ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DRUG DERIVATIVE; MEVINOLIN; SIMVASTATIN;

ARTICLE; BLOOD PRESSURE; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; HEART; HEART STROKE VOLUME; HEART TRANSPLANTATION; HUMAN; MALE; MIDDLE AGED; PHYSIOLOGY; PROSPECTIVE STUDY;

ANTILIPEMIC AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; ECHOCARDIOGRAPHY; FEMALE; HEART; HEART TRANSPLANTATION; HUMANS; LOVASTATIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SIMVASTATIN; STROKE VOLUME;

EID: 0030589255     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00637-6     Document Type: Article

References (22)

1. Barbir M, Rose M, Kushwaha S, Akl S, Mitchell A, Yacoub M. Low-dose simvastatin for the treatment of hypercholesterolaemia in recipients of cardiac transplantation. Int J Cardiol 1991;33:241-246.
2. Kobashigawa JA, Katznelson S, Laks H, Johnson JA, Yeatman L, Wang XM, Chea D, Terasaki PI, Sabad A, Cogert GA, Trosian K, Hamilton MA, Moriguchi A, Kawata N, Hage A, Drinkwater DC, Stevenson WS. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995;333:621-627.
3. Sahn D, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1483.
4. Troy B, Pombo J, Rackley C. Measurement of left ventricular wall thickness and mass by echocardiography. Circulation 1972;45:602-611.
5. Du Bois D, Du Bois E. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916;17:863-871.
6. Smith JD, Rose ML, Pomerance A, Burke M, Yacoub MH. Reduction of cellular rejection and increase in long term survival after heart transplantation after HLA-DR matching. Lancet 1995;346:1318-1322.
7. Billingham ME, Nathaniel RBC, Hammond ME, Kemnitz J, Marboe C, McCallister HA, Snovar DC, Winters GL, Zerbe A. A working formulation for the standardisation of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Transplant 1990;9:587-593.
8. Beresini M, Toton-Quinn R. EMIT cyclosporin assay for whole blood cyclosporin for the Cobas-Mira analyser (abstr). Clin Chem 1990;36:1034.
9. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 1990;343:425-430.
10. Munro E, Patel M, Chan P, Betteridge L, Clunn G, Gallagher K, Hughes A, Schachter M, Wolfe J, Sever P. Inhibition of human vascular smooth muscle cell proliferation by lovastatin: the role of isoprenoid intermediates in cholesterol synthesis. Eur J Clin Invest 1994;24:766-772.
11. Kubo SH, Naaftel DC, Mills RM, O'Donnell J, Rodeheffer RJ, Cintron GB, Kenzora JL, Bourge RC, Kirklin JK. Risk factors for late recurrent rejection after heart transplantation. J Heart Lung Transplant 1995;14:409-418.
12. Esmore D, Keogh A, Spratt P, Jones B, Chang V. Heart transplantation in females. J Heart Lung Transplant 1991;10:335-341.
13. De Divitiis O, Fazio S, Petitto M, Maddalena G, Contaldo F, Mancini M. Obesity and cardiac function. Circulation 1981;64:477-481.
14. Port S, Cobb F, Coleman R, Jones R. Effect of age on the response of the left ventricular ejection fraction to exercise. N Engl J Med 1980:303:1133-1137.
15. Raine AEG. The heart and renal failure. Contrib Nephrol 1994;109:76-83.
16. Shepherd R, Zachariah P, Shub C. Hypertension and left ventricular diastolic function. Mayo Clin Proc 1989;64:1521-1532.
17. Ozdogan E, Banner NR, Fitzgerald M, Musumeci F, Khagani A, Yacoub M. Factors influencing the development of hypertension following cardiac transplantation. J Heart Lung Transplant 1990;5:548-553.
18. Dahlof B, Pennert K, Hansson L. Regression of left ventricular hypertrophy - a meta analysis. Clin Exp Hypertens A 1992:14:173-180.
19. Parameshwar J, Schofield P, Large S. Long-term complications of cardiac transplantation. Br Heart J 1995:74:341-342.
20. Gotto AM, LaRosa JC, Hunninghake D, Grundy SM, Wilson PW, Clarkson TB, Hay JW, Goodman DS. The cholesterol facts. Circulation 1990;81:1721-1733.
21. Ballantyne CM. Drugs in cardiac transplantation. N Engl J Med 1996;334:400-401.
22. McPherson R, Tsoukas C, Baines M, Vost A, Melino M, Zupkis R, Pross H. Effects of lovastatin on natural killer cell function and other immunological parameters in man. J Clin Immunol 1993;13:439-444.